Clinical Trials

Condition or Disease

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

2 studies in Menstrual Disorders

  1. Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery Scottsdale and Phoenix, AZ View Summary

    Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery

    Location:

    Scottsdale and Phoenix, AZ

    Trial status:

    Open for Enrollment

    Why is this study being done?

    Our primary aim is to determine whether the routine use of belladonna and morphine suppositories will improve pain control following vaginal surgery. Treatment will begin immediately following surgery and every 8 hours for 16 hours.

    NCT ID:

    NCT01150474

    IRB Number:

    09-008045

    Who can I contact for additional information about this study?


    Scottsdale: Debbie Ryan 480-342-1208
                        Kristina Butler, M.D. 507-266-7712

  2. Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia Rochester, MN View Summary

    Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia

    Location:

    Rochester, MN

    Trial status:

    Open for Enrollment

    Why is this study being done?

    Goal of study: To evaluate the safety, effectiveness as well as cost- effectiveness of Global Endometrial Ablation (GEA) as an initial treatment for menorrhagia. Specific aim #1: To determine if global endometrial ablation (GEA) is more effective than medical therapy in the initial management of menorrhagia. Specific aim #2: To determine disease-specific resource utilization and costs associated with the treatment alternatives and the cost effectiveness of global endometrial ablation (GEA) compared with medical treatment (oral contraceptive pills) in the initial management of menorrhagia.

    NCT ID:

    NCT01165307

    Who can I contact for additional information about this study?

    Rochester: Maureen Lemens, BSN 507-293-1487
                        


Contact us

Clinical studies questions

Cancer-related clinical studies questions

International patient clinical studies questions